Navigation Links
Sustained Viral Response from Phase 2 Studies of BI 201335, Including Difficult-to-Treat HCV Patient Types
Date:11/8/2011

BI 201335 on the background of 24 weeks of PegIFN/RBV was sufficient to achieve sustained viral response (SVR).  Patients with undetectable viral load prior to week 8 had similar SVR rates, whether they were treated for 12 or 24 weeks with BI 201335 (80 percent and 82 percent, respectively).

The most frequent adverse events (AEs) in SILEN-C3 were mild gastrointestinal disorders, rash, photosensitivity and jaundice due to isolated unconjugated hyperbilirubinemia.

In this open-label Phase 2 trial, 159 treatment-naive GT1 HCV patients were randomized to receive 120 mg BI 201335 once daily for 12 or 24 weeks, each after three days lead-in (LI) with PegIFN/RBV.  In both groups, PegIFN/RBV was given for 24 weeks.  Patients who did not have an eRVR continued PegIFN/RBV to week 48.  eRVR was defined as viral load less than 25 IU/mL at week 4 and undetectable at weeks 8-18.  In the 12 week treatment group, 72 percent of patients had an eRVR and in the 24 week treatment group, 82 percent of patients had an eRVR.

(Abstract #226) Treatment with the 2nd Generation HCV Protease Inhibitor BI 201335 Results in High and Consistent SVR Rates – Results from SILEN-C1 in Treatment-Naive Patients Across Different Baseline Factors

This analysis of SILEN-C1 evaluated SVR according to various baseline characteristics among patients who received BI 201335 240 mg once daily without LI.

The majority of patients with more difficult-to-treat HCV types – specifically GT1a and IL-28B non-CC allele patients – achieved SVR.  Among patients with GT1a HCV (n=32), a type that traditionally is associated with lower treatment response rates compared to GT1b, 82 percent achieved SVR.  Among GT1b HCV patients (n=38), 84 percent achieved SVR.  In addition, SVR was 71 percent for patients with non-CC alleles of the IL-28B gene (n=29).  Patients with CC alleles (n=11) or for whom IL-28B genotyping wa
'/>"/>

SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
2. Cypher(R) Sirolimus-Eluting Coronary Stent Demonstrates Sustained Clinical Benefits Compared to Bare Metal Stents in Five-Year Randomized Clinical Trial With No Differences in Long-Term Safety
3. Lotus Pharmaceuticals, Inc. Achieves Significant Milestones in the Development of Isosorbide Mononitrate Sustained Release Tablets
4. FTY720, a novel oral therapy in development for MS, shows sustained benefits for the majority of patients after three years of treatment
5. CERVARIX(R) Shown to Provide Longest Duration of Sustained Neutralizing Antibodies to Date
6. After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURATION-1 Presented at ADA 2008
7. Schering-Plough Announces Phase III Data for Sustained Follicle Stimulant
8. Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III Melanoma Demonstrated Significant and Sustained Impact on Relapse-Free Survival
9. FDA Updates Label for AVANDIA(R) to Include Clinical Findings Demonstrating Sustained Glycemic Control for Up to Five Years
10. Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients
11. Spherics, Inc. Offers Extended Release Formulation for Sustained and Stable Levodopa Levels
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... , May 21, 2013  Armada Health ... of the new Armada corporate website ( www.armadahealthcare.com ... communicate Armada,s unique and first-to-market services and its ... focused on the specialty pharmacy industry. ... of the Armada business model in delivering an ...
(Date:5/21/2013)... 21, 2013  Cephasonics, a technology-innovation leader ... the introduction of the cQuest Ultrasound SDK™ ... with all cQuest Ultrasound™ hardware platforms. Cephasonics ... this new capability, at Hospitalar 2013 held ... from May 21-24.  Cephasonics is located ...
(Date:5/21/2013)... , May 21, 2013 Hurel Corporation ("Hurel"), ... microfluidic cell-based assay platforms, today announced the appointment of ... to the Company,s Board of Directors. Dr. MacDonald is ... the Schering-Plough Research Institute ("SPRI"), which was the pharmaceutical ... by Merck & Co. in 2009. Over ...
Breaking Medicine Technology:Armada Announces New Corporate Website to Showcase Expanded Services to Specialty Pharmacy Marketplace 2Cephasonics Unveils Next-Generation Wireless-Imaging Technology for cQuest Ultrasound Hardware Platforms 2Hurel Corporation Appoints Leading Pharmaceutical Executive and Toxicologist Dr. James S. MacDonald to Board of Directors 2
... Reportlinker.com announces that a new market research ... Vaccines - Western Europe ... market research report package offers an in-depth perspective ... outlook for vaccines in Western European markets. The ...
... 2012 Reportlinker.com announces that a new ... catalogue: Pharmaceuticals: Global ... http://www.reportlinker.com/p0191852/Pharmaceuticals-Global-Industry-Guide.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pharmaceu Pharmaceuticals: Global Industry ... data and analysis covering the Pharmaceuticals industry. ...
Cached Medicine Technology:Vaccines - Western Europe 2Pharmaceuticals: Global Industry Guide 2Pharmaceuticals: Global Industry Guide 3Pharmaceuticals: Global Industry Guide 4Pharmaceuticals: Global Industry Guide 5Pharmaceuticals: Global Industry Guide 6Pharmaceuticals: Global Industry Guide 7Pharmaceuticals: Global Industry Guide 8Pharmaceuticals: Global Industry Guide 9Pharmaceuticals: Global Industry Guide 10Pharmaceuticals: Global Industry Guide 11Pharmaceuticals: Global Industry Guide 12Pharmaceuticals: Global Industry Guide 13Pharmaceuticals: Global Industry Guide 14Pharmaceuticals: Global Industry Guide 15
(Date:5/22/2013)... Athletic-Minded Traveler LLC, a San ... today its 2013 U.S. Business Hotel “Fit List”. ... company’s recommendation after ongoing research of over 3,500 ... the editorial staff. Selection criteria included hotel ... etc.), in-room workout choices, healthy food offerings, cost, ...
(Date:5/21/2013)... 2013 Spring is the perfect time ... markets filled with whole foods to weather perfect for ... the season the nutrition experts at Brilliant Nutrition highlight ... miss. , 1. Eating Locally, With the abundance of ... linger and explore, spring is a great time to ...
(Date:5/21/2013)... Dallas, Texas (PRWEB) May 22, 2013 ... globally increasing meat production industry value chain. Most of ... the form of injectable, pellets, liquids, and powders. There ... in different quantities and concentrations depending upon the type ... acids, minerals, and vitamins that provide essential nutrition to ...
(Date:5/21/2013)... Denver, Colorado (PRWEB) May 21, 2013 Daily ... the life of their readers and keep people informed on ... , This week, reporters have prepared an in-depth review ... which could be useful for readers who want to lose ... , According to Daily Gossip the program was created by ...
(Date:5/21/2013)... DISCcert has served the training industry for ... DISC applications at the July 25 & 26th ... July 25 & 26th DISC certification in San Diego, ... DISC. The time-tested, proven support materials will include valuable ... training materials ; worksheets, handouts, learning activities, power-points ...
Breaking Medicine News(10 mins):Health News:2013: The 10 Healthiest Business Hotels in the U.S. 2Health News:Brilliant Nutrition Offers 5 Ways to Live Healthier and Inspired this Spring 2Health News:Brilliant Nutrition Offers 5 Ways to Live Healthier and Inspired this Spring 3Health News:Protease Leads Feed Enzyme Market as Compared to Phytase & NSP Says New Research Report at ReportsnReports.com 2Health News:Protease Leads Feed Enzyme Market as Compared to Phytase & NSP Says New Research Report at ReportsnReports.com 3Health News:Protease Leads Feed Enzyme Market as Compared to Phytase & NSP Says New Research Report at ReportsnReports.com 4Health News:Customized Fat Loss Plan Review and Diet Secrets Revealed By Daily Gossip Magazine 2Health News:DISCcert Offers 17 Applications in Coming DISC Certification 2Health News:DISCcert Offers 17 Applications in Coming DISC Certification 3Health News:DISCcert Offers 17 Applications in Coming DISC Certification 4
... use of Zetia and ... Vytorin., ... Jersey appointed Hagens Berman, along with four other firms, co-counsel,in a case ... which,claims the companies knowingly misled consumers on the use of popular,prescription drugs ...
... Senators John McCain, Hillary Clinton and Barack Obama all ... terror" as they campaigned across the U.S. this year. ... be treated to a psychological perspective of the candidates, ... Meeting. Attendees of the Presidential Symposium will hear ...
... Study found doctors with patients of both races still showed ... New research shows that black patients with diabetes tend to ... the same doctor. , In other words, the gap can,t ... care. Racial disparities in diabetes care appear to be more ...
... Sysmex America, Inc. (SAI),today announced the ... (SNCS) at Hagerstown Medical Laboratory, Maryland.,SNCS is ... continuously collects,and tracks instrument performance data from ... and Support. SNCS enables proactive response to ...
... Disappear or be Hindered For ... California,s Most Vulnerable Citizens, SACRAMENTO, Calif., June 10 ... California Department of,Health Care Services and its director Sandra Shewry ... going into effect on July 1,2008. The action claims that ...
... Entertainment & Year Round Events Collaborate on Raising Awareness ... and Funding for Breast Cancer Research & Education, ... today announced,the formation of a new multilevel branding initiative, ... and events, with a,percentage of the sales earmarked for ...
Cached Medicine News:Health News:Hagens Berman Appointed Co-Lead Counsel in Case Against Schering-Plough and Merck 2Health News:Hagens Berman Appointed Co-Lead Counsel in Case Against Schering-Plough and Merck 3Health News:The forever war on terror: Dilemmas and choices 2Health News:No Matter the Doctor, Black Diabetics Fare Worse Than White Counterparts 2Health News:No Matter the Doctor, Black Diabetics Fare Worse Than White Counterparts 3Health News:Sysmex America to Enable Prolonged Hematology Instrument Uptime for Hagerstown Medical Laboratory With 1,000th SNCS Activation 2Health News:Sysmex America to Enable Prolonged Hematology Instrument Uptime for Hagerstown Medical Laboratory With 1,000th SNCS Activation 3Health News:Eight California Pharmacies File Lawsuit Against the California Department of Health Care Services to Stop the 10 Percent Medi-Cal Provider Cuts to Pharmacies 2Health News:PiNKiTUDE, New Cause Marketing Initiative Inspired by MGM's Pink Panther, Benefits Susan G. Komen for the Cure(R) 2Health News:PiNKiTUDE, New Cause Marketing Initiative Inspired by MGM's Pink Panther, Benefits Susan G. Komen for the Cure(R) 3Health News:PiNKiTUDE, New Cause Marketing Initiative Inspired by MGM's Pink Panther, Benefits Susan G. Komen for the Cure(R) 4
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: